A lifecourse approach to reducing the burden of osteoporotic fractures
Research at the MRC Lifecourse Epidemiology Unit has improved bone density in younger people and reduced osteoporosis and fracture rates in older age.
Read more
We have an outstanding reputation and are committed to the pursuit of excellence in biomedical sciences and clinical research. In the 2014 REF, 94% of the Faculty's research was rated 3 or 4* for impact. Our vision is to translate biomedical research into clinical outcomes that improve health worldwide. Below we feature just some examples of the ways that our research is impacting on lives of people in UK, and all over the world.
Research at the MRC Lifecourse Epidemiology Unit has improved bone density in younger people and reduced osteoporosis and fracture rates in older age.
Southampton scientists have developed, trialled and commercialised a successful therapy for virus-induced inflammatory lung conditions including asthma, chronic obstructive pulmonary disease and COVID-19.
A point of care test developed in Southampton for the trials, provides COVID-19 test results in one hour – a dramatic reduction from one day.
Our longstanding research in antibiotic prescribing has made major contributions to the global fight against antimicrobial resistance.
Our research has defined new standards of care and changed clinical practice for cancers of the gastrointestinal tract worldwide.
We have helped develop the next generation of cancer drugs based on monoclonal antibodies, leading to improved treatment for millions of patients and substantial economic benefit.
Our research in medical epigenetics has changed the way imprinted disorders are diagnosed and treated, improving the lives of patients around the world.
Our multidisciplinary research has resulted in the development of ‘POWeR’ – Positive Online Weight Reduction – a self-guided digital intervention to initiate and sustain weight loss and physical activity. POWeR has been taken up by local health authorities, making it available to millions.
We have made key discoveries demonstrating that the diet and lifestyle of prospective parents and pregnant mothers can have a critical impact on the long-term health of their children, and that such impacts can be mitigated by changes in diet and lifestyle.
Our longstanding body of respiratory research has led to significant changes in government legislation, national and regional policy, and public awareness of the health effects of air pollution.
Our stem cell research has led to the use of novel biomaterial scaffolds in the treatment of bone damage and disease.
Lymphoma and lymphocytic leukaemia are common types of malignancy, and modern treatments have resulted in steadily improving survival rates. Our research has made seminal contributions to understanding the pathogenesis, prognosis and treatment of lymphoid malignancies, with results that have been translated into direct benefit for patients.
Our research has discovered a cost-effective treatment for age-related macular degeneration, as well as the first ever treatment for Sorsby fundus dystrophy, a rare juvenile form of macular degeneration.